HCPLive

Gastroesophageal Reflux Disease (GERD)
The MD Magazine Gastroesophageal Reflux Disease (GERD) condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Proton Pump Inhibitors Linked to Increased Risk of MI
For US adults with gastroesophageal reflux disease (GERD), the risk of myocardial infarction (MI) is slightly elevated among those using proton pump inhibitors, according to a review published online June 10 in PLOS ONE.

Research recently published in the Journal of Molecular Diagnostics reveals a new next-generation sequencing (NGS) test to detect genomic mutations in precarious esophageal tissue – potentially improving early detection in individuals with Barrett’s esophagus (BE).
Anxiety and depression are linked to increased severity of retrosternal pain and heartburn and reduced quality of life among patients with gastroesophageal reflux disease, according to a study published in the June issue of Clinical Gastroenterology and Hepatology.
For patients with gastroesophageal reflux disease (GERD), evidence shows no difference in physiologic parameters for treatment with a radiofrequency ablation technique known as Stretta versus sham or proton pump inhibitor (PPI) therapy, according to a review published in the June issue of Clinical Gastroenterology and Hepatology.

A study in JAMA Surgery identified several factors that cause a frequently used antireflux surgery to be unsuccessful.
Concomitant use of metformin and histamine H2-receptor antagonists or proton pump inhibitors has the potential to induce vitamin B12 depletion and neuropathy, according to research published in the April issue of Clinical Diabetes.
Nocturnal gastroesophageal reflux disease (GERD) appears to be a risk factor for non-infectious rhinitis (NIR), according to a study published online March 24 in Allergy.

Most Popular

$vacMongoViewPlus$ $vAR$